ATC Group: J01CA04 Amoxicillin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J01CA04 in the ATC hierarchy

Level Code Title
1 J Antiinfectives for systemic use
2 J01 Antibacterials for systemic use
3 J01C Beta-lactam antibacterials, penicillins
4 J01CA Penicillins with extended spectrum
5 J01CA04 Amoxicillin

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 1 g
PAREN - Parenteral 1 g

Active ingredients in J01CA04

Active Ingredient Description
Amoxicillin

Amoxicillin is a semisynthetic penicillin (beta-lactam antibiotic) that inhibits one or more enzymes (often referred to as penicillin-binding proteins, PBPs) in the biosynthetic pathway of bactericidal peptidoglycan, which is an integral structural component of the bacterial cell wall. Inhibition of peptidoglycan synthesis leads to weakening of the cell wall, which is usually followed by cell lysis and death.

Related product monographs

Title Information Source Document Type  
AMOXAPEN Film-coated tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
AMOXIL Capsule Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
BETAMOX Capsule, Suspension Health Products Regulatory Authority (ZA) MPI, Generic
EDAMOX Hard capsule Υπουργείο Υγείας (CY) MPI, EU: SmPC
MOXARIN Capsule, hard Υπουργείο Υγείας (CY) MPI, EU: SmPC
MOXILEN Capsule, Powder for oral suspension, Powder for solution for injection Υπουργείο Υγείας (CY) MPI, EU: SmPC
OSPAMOX Powder for oral suspension / Paediatric drops Medicines and Medical Devices Safety Authority (NZ) MPI, EU: SmPC
ULTRAMOX Capsule Marketing Authorisation Holder MPI, Generic

Medicines in this ATC group

United States (US)

Austria (AT)

Canada (CA)

Estonia (EE)

Finland (FI)

France (FR)

Germany (DE)

Ireland (IE)

Israel (IL)

Lithuania (LT)

Mexico (MX)

Romania (RO)

Spain (ES)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.